T
0.300
-0.02 (-4.76%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (MY) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | TOPVISN | - | - |
AIStockmoo Score
0.4
| Analyst Consensus | 0.0 |
| Insider Activity | 3.0 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | 0.40 |
|
Topvision Eye Specialist Bhd is principally involved in the provision of ophthalmology services and related medical consultancy services. It is also engaged in the marketing of eye supplements and health food products, and the retail sale of food and beverages. The company derives a majority of its revenue from its ophthalmology services business, providing treatments for general as well as complex eye diseases. Geographically, it operates in Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DR AZIDA JUANA BINTI WAN AB KADIR | 0.340 | - | 100,000 | 34,000 |
| MR LEE GEOK AI | 0.340 | - | 110,000 | 37,400 |
| DATUK LIEW HOCK NEAN | 0.340 | - | 1,003,000 | 341,020 |
| MADAM LIM MAY WAN | 0.340 | - | 100,000 | 34,000 |
| DR. PETER CHONG KUOK SIONG | 0.340 | - | 635,000 | 215,900 |
| MR TAN KAH POH | 0.340 | - | 100,000 | 34,000 |
| Aggregate Net Quantity | 2,048,000 | |||
| Aggregate Net Value ($) | 696,320 | |||
| Aggregate Avg. Buy ($) | 0.340 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MR LEE GEOK AI | Director | 16 Dec 2024 | Acquired (+) | 110,000 | 0.340 | 37,400 |
| MR TAN KAH POH | Director | 16 Dec 2024 | Acquired (+) | 100,000 | 0.340 | 34,000 |
| MADAM LIM MAY WAN | Director | 16 Dec 2024 | Acquired (+) | 100,000 | 0.340 | 34,000 |
| DR. PETER CHONG KUOK SIONG | Director | 16 Dec 2024 | Acquired (+) | 435,000 | 0.340 | 147,900 |
| DR. PETER CHONG KUOK SIONG | Director | 16 Dec 2024 | Acquired (+) | 200,000 | 0.340 | 68,000 |
| DATUK LIEW HOCK NEAN | Director | 16 Dec 2024 | Acquired (+) | 532,500 | 0.340 | 181,050 |
| DATUK LIEW HOCK NEAN | Director | 16 Dec 2024 | Acquired (+) | 470,500 | 0.340 | 159,970 |
| DR AZIDA JUANA BINTI WAN AB KADIR | Director | 16 Dec 2024 | Acquired (+) | 100,000 | 0.340 | 34,000 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |